This application relates to compounds of the formula ##STR1## wherein R.sup.1, X, Y and n are as defined in the specification; and pharmaceutically acceptable addition salts thereof and optical and geometric isomers or racemic mixtures thereof; which compounds are useful for the treatment of various memory dysfunctions characterized by a decreased cholinergic function such as Alzheimer's disease. Compounds of this invention also inhibit monoamine oxidase and hence are useful as antidepressants.
这种应用涉及到式##STR1##的化合物,其中R.sup.1、X、Y和n如规范中所定义;以及其药学上可接受的加合盐和其光学和几何异构体或消旋混合物;这些化合物对于治疗由于
胆碱功能降低而表现出的各种记忆功能障碍,如阿尔茨海默病,是有用的。本发明的化合物还抑制单胺氧化酶,因此可用作抗抑郁药。